4.6 Article

COVID-19 Vaccine Safety Surveillance in Early Pregnancy in the United States: Design Factors Affecting the Association Between Vaccine and Spontaneous Abortion

Journal

AMERICAN JOURNAL OF EPIDEMIOLOGY
Volume 192, Issue 8, Pages 1386-1395

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/aje/kwad059

Keywords

case-control; COVID-19 vaccines; pregnancy; safety; spontaneous abortion; study design; surveillance

Ask authors/readers for more resources

In this study, we investigated the association between COVID-19 vaccination during early pregnancy and spontaneous abortion (SAB) by analyzing data from the Vaccine Safety Datalink. We found that the observed protective effect of the vaccine on SAB was attenuated when the surveillance period extended from March 8, 2021, to June 28, 2021. We also explored different methodological approaches and found that the timing of the surveillance played a significant role in the observed vaccine-SAB association.
In the Vaccine Safety Datalink (VSD), we previously reported no association between coronavirus disease 2019 (COVID-19) vaccination in early pregnancy and spontaneous abortion (SAB). The present study aims to understand how time since vaccine rollout or other methodological factors could affect results. Using a case-control design and generalized estimating equations, we estimated the odds ratios (ORs) of COVID-19 vaccination in the 28 days before a SAB or last date of the surveillance period (index date) in ongoing pregnancies and occurrence of SAB, across cumulative 4-week periods from December 2020 through June 2021. Using data from a single site, we evaluated alternative methodological approaches: increasing the exposure window to 42 days, modifying the index date from the last day to the midpoint of the surveillance period, and constructing a cohort design with a time-dependent exposure model. A protective effect (OR = 0.78, 95% confidence interval: 0.69, 0.89), observed with 3-cumulative periods ending March 8, 2021, was attenuated when surveillance extended to June 28, 2021 (OR = 1.02, 95% confidence interval: 0.96, 1.08). We observed a lower OR for a 42-day window compared with a 28-day window. The time-dependent model showed no association. Timing of the surveillance appears to be an important factor affecting the observed vaccine-SAB association.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available